| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.75e-09 | 16 | 32 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | calcium ion binding | DNER LRP2 VLDLR THBS1 THBS2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 1.21e-08 | 749 | 32 | 11 | GO:0005509 |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.19e-08 | 21 | 32 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | recombination hotspot binding | 2.49e-06 | 2 | 32 | 2 | GO:0010844 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.00e-05 | 85 | 32 | 4 | GO:0038024 | |
| GeneOntologyMolecularFunction | Notch binding | 1.07e-05 | 27 | 32 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | 6.28e-05 | 268 | 32 | 5 | GO:0005539 | |
| GeneOntologyMolecularFunction | sulfur compound binding | 1.51e-04 | 323 | 32 | 5 | GO:1901681 | |
| GeneOntologyMolecularFunction | Roundabout binding | 1.63e-04 | 12 | 32 | 2 | GO:0048495 | |
| GeneOntologyMolecularFunction | histone H3K36 methyltransferase activity | 1.92e-04 | 13 | 32 | 2 | GO:0046975 | |
| GeneOntologyMolecularFunction | heparin binding | 2.41e-04 | 192 | 32 | 4 | GO:0008201 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 4.18e-04 | 19 | 32 | 2 | GO:0005520 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 4.64e-04 | 20 | 32 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 6.16e-04 | 23 | 32 | 2 | GO:0030215 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 9.83e-04 | 29 | 32 | 2 | GO:0045499 | |
| GeneOntologyMolecularFunction | lipoprotein particle binding | 1.43e-03 | 35 | 32 | 2 | GO:0071813 | |
| GeneOntologyMolecularFunction | protein-lipid complex binding | 1.43e-03 | 35 | 32 | 2 | GO:0071814 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.96e-03 | 156 | 32 | 3 | GO:0019838 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 2.26e-03 | 44 | 32 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 2.78e-03 | 616 | 32 | 5 | GO:0030545 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 3.02e-03 | 51 | 32 | 2 | GO:0043394 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 5.31e-03 | 68 | 32 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 5.46e-03 | 69 | 32 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 5.77e-03 | 71 | 32 | 2 | GO:0042054 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | OBSL1 LRP2 VLDLR SEMA5A NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 1.16e-07 | 748 | 32 | 10 | GO:0048667 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | OBSL1 LRP2 VLDLR SEMA5A NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 2.21e-07 | 802 | 32 | 10 | GO:0048812 |
| GeneOntologyBiologicalProcess | axon guidance | 2.24e-07 | 285 | 32 | 7 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 2.29e-07 | 286 | 32 | 7 | GO:0097485 | |
| GeneOntologyBiologicalProcess | cardiac septum morphogenesis | 2.45e-07 | 89 | 32 | 5 | GO:0060411 | |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | OBSL1 LRP2 VLDLR SEMA5A NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 2.69e-07 | 819 | 32 | 10 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | OBSL1 LRP2 VLDLR SEMA5A NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 2.91e-07 | 826 | 32 | 10 | GO:0048858 |
| GeneOntologyBiologicalProcess | semi-lunar valve development | 1.04e-06 | 50 | 32 | 4 | GO:1905314 | |
| GeneOntologyBiologicalProcess | negative chemotaxis | 1.13e-06 | 51 | 32 | 4 | GO:0050919 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.80e-06 | 566 | 32 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | cardiac septum development | 1.88e-06 | 134 | 32 | 5 | GO:0003279 | |
| GeneOntologyBiologicalProcess | neuron projection development | OBSL1 LRP2 VLDLR SEMA5A LRP12 NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 2.01e-06 | 1285 | 32 | 11 | GO:0031175 |
| GeneOntologyBiologicalProcess | heart valve morphogenesis | 2.66e-06 | 63 | 32 | 4 | GO:0003179 | |
| GeneOntologyBiologicalProcess | pulmonary valve morphogenesis | 3.80e-06 | 20 | 32 | 3 | GO:0003184 | |
| GeneOntologyBiologicalProcess | axon development | 4.58e-06 | 642 | 32 | 8 | GO:0061564 | |
| GeneOntologyBiologicalProcess | cardiac chamber morphogenesis | 4.62e-06 | 161 | 32 | 5 | GO:0003206 | |
| GeneOntologyBiologicalProcess | heart valve development | 6.28e-06 | 78 | 32 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | pulmonary valve development | 6.71e-06 | 24 | 32 | 3 | GO:0003177 | |
| GeneOntologyBiologicalProcess | cellular response to tumor cell | 6.99e-06 | 3 | 32 | 2 | GO:0071228 | |
| GeneOntologyBiologicalProcess | neuron development | OBSL1 LRP2 VLDLR SEMA5A LRP12 NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 7.06e-06 | 1463 | 32 | 11 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell morphogenesis | OBSL1 LRP2 VLDLR SEMA5A NTNG2 IGFALS SEMA5B NOTCH1 NOTCH2 SLIT3 | 8.13e-06 | 1194 | 32 | 10 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of endothelial cell chemotaxis | 8.61e-06 | 26 | 32 | 3 | GO:2001026 | |
| GeneOntologyBiologicalProcess | heart morphogenesis | 8.74e-06 | 321 | 32 | 6 | GO:0003007 | |
| GeneOntologyBiologicalProcess | chemotaxis | 1.17e-05 | 517 | 32 | 7 | GO:0006935 | |
| GeneOntologyBiologicalProcess | taxis | 1.20e-05 | 519 | 32 | 7 | GO:0042330 | |
| GeneOntologyBiologicalProcess | outflow tract morphogenesis | 1.32e-05 | 94 | 32 | 4 | GO:0003151 | |
| GeneOntologyBiologicalProcess | positive regulation of reciprocal meiotic recombination | 1.40e-05 | 4 | 32 | 2 | GO:0010845 | |
| GeneOntologyBiologicalProcess | regulation of reciprocal meiotic recombination | 1.40e-05 | 4 | 32 | 2 | GO:0010520 | |
| GeneOntologyBiologicalProcess | cardiac chamber development | 1.76e-05 | 212 | 32 | 5 | GO:0003205 | |
| GeneOntologyBiologicalProcess | endothelial cell chemotaxis | 2.15e-05 | 35 | 32 | 3 | GO:0035767 | |
| GeneOntologyBiologicalProcess | aortic valve morphogenesis | 2.98e-05 | 39 | 32 | 3 | GO:0003180 | |
| GeneOntologyBiologicalProcess | inhibition of neuroepithelial cell differentiation | 3.48e-05 | 6 | 32 | 2 | GO:0002085 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 3.48e-05 | 6 | 32 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.48e-05 | 6 | 32 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 3.87e-05 | 418 | 32 | 6 | GO:0051962 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 3.94e-05 | 625 | 32 | 7 | GO:0051960 | |
| GeneOntologyBiologicalProcess | negative regulation of endothelial cell chemotaxis | 4.87e-05 | 7 | 32 | 2 | GO:2001027 | |
| GeneOntologyBiologicalProcess | aortic valve development | 4.92e-05 | 46 | 32 | 3 | GO:0003176 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 5.25e-05 | 47 | 32 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | negative regulation of chemotaxis | 7.97e-05 | 54 | 32 | 3 | GO:0050922 | |
| GeneOntologyBiologicalProcess | atrioventricular node development | 8.34e-05 | 9 | 32 | 2 | GO:0003162 | |
| GeneOntologyBiologicalProcess | positive regulation of cardiac epithelial to mesenchymal transition | 8.34e-05 | 9 | 32 | 2 | GO:0062043 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 9.38e-05 | 57 | 32 | 3 | GO:0061005 | |
| GeneOntologyBiologicalProcess | endocardial cushion development | 9.88e-05 | 58 | 32 | 3 | GO:0003197 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 1.04e-04 | 10 | 32 | 2 | GO:0072310 | |
| GeneOntologyBiologicalProcess | coronary artery morphogenesis | 1.04e-04 | 10 | 32 | 2 | GO:0060982 | |
| GeneOntologyBiologicalProcess | podocyte development | 1.04e-04 | 10 | 32 | 2 | GO:0072015 | |
| GeneOntologyBiologicalProcess | distal tubule development | 1.04e-04 | 10 | 32 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | cardiac ventricle development | 1.08e-04 | 161 | 32 | 4 | GO:0003231 | |
| GeneOntologyBiologicalProcess | heart development | 1.32e-04 | 757 | 32 | 7 | GO:0007507 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 1.99e-04 | 354 | 32 | 5 | GO:0050769 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelial sheet | 2.04e-04 | 74 | 32 | 3 | GO:0002011 | |
| GeneOntologyBiologicalProcess | negative regulation of cell-substrate adhesion | 2.04e-04 | 74 | 32 | 3 | GO:0010812 | |
| GeneOntologyBiologicalProcess | left/right axis specification | 2.10e-04 | 14 | 32 | 2 | GO:0070986 | |
| GeneOntologyBiologicalProcess | regulation of cardiac epithelial to mesenchymal transition | 2.10e-04 | 14 | 32 | 2 | GO:0062042 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 2.11e-04 | 817 | 32 | 7 | GO:0048514 | |
| GeneOntologyBiologicalProcess | endocytosis | 2.27e-04 | 827 | 32 | 7 | GO:0006897 | |
| GeneOntologyBiologicalProcess | glomerulus development | 2.30e-04 | 77 | 32 | 3 | GO:0032835 | |
| GeneOntologyBiologicalProcess | regulation of timing of cell differentiation | 2.42e-04 | 15 | 32 | 2 | GO:0048505 | |
| GeneOntologyBiologicalProcess | circulatory system development | 2.50e-04 | 1442 | 32 | 9 | GO:0072359 | |
| GeneOntologyBiologicalProcess | mesenchyme development | 2.51e-04 | 372 | 32 | 5 | GO:0060485 | |
| GeneOntologyBiologicalProcess | kidney development | 2.51e-04 | 372 | 32 | 5 | GO:0001822 | |
| GeneOntologyBiologicalProcess | positive regulation of neural precursor cell proliferation | 2.57e-04 | 80 | 32 | 3 | GO:2000179 | |
| GeneOntologyBiologicalProcess | aorta development | 2.57e-04 | 80 | 32 | 3 | GO:0035904 | |
| GeneOntologyBiologicalProcess | neuroendocrine cell differentiation | 2.76e-04 | 16 | 32 | 2 | GO:0061101 | |
| GeneOntologyBiologicalProcess | renal system development | 2.97e-04 | 386 | 32 | 5 | GO:0072001 | |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 3.00e-04 | 210 | 32 | 4 | GO:0007219 | |
| GeneOntologyBiologicalProcess | regulation of development, heterochronic | 3.13e-04 | 17 | 32 | 2 | GO:0040034 | |
| GeneOntologyBiologicalProcess | cardiac ventricle morphogenesis | 3.40e-04 | 88 | 32 | 3 | GO:0003208 | |
| GeneOntologyBiologicalProcess | neural crest cell development | 3.52e-04 | 89 | 32 | 3 | GO:0014032 | |
| GeneOntologyBiologicalProcess | ventricular septum development | 3.76e-04 | 91 | 32 | 3 | GO:0003281 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.88e-04 | 92 | 32 | 3 | GO:0048844 | |
| GeneOntologyBiologicalProcess | blood vessel development | 4.60e-04 | 929 | 32 | 7 | GO:0001568 | |
| GeneOntologyBiologicalProcess | response to muramyl dipeptide | 4.81e-04 | 21 | 32 | 2 | GO:0032495 | |
| GeneOntologyBiologicalProcess | cardiac right ventricle morphogenesis | 4.81e-04 | 21 | 32 | 2 | GO:0003215 | |
| GeneOntologyBiologicalProcess | stem cell development | 5.10e-04 | 101 | 32 | 3 | GO:0048864 | |
| GeneOntologyBiologicalProcess | podocyte differentiation | 5.28e-04 | 22 | 32 | 2 | GO:0072112 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell differentiation | 5.28e-04 | 22 | 32 | 2 | GO:0072311 | |
| GeneOntologyBiologicalProcess | axon extension involved in axon guidance | 5.28e-04 | 22 | 32 | 2 | GO:0048846 | |
| GeneOntologyBiologicalProcess | renal filtration cell differentiation | 5.28e-04 | 22 | 32 | 2 | GO:0061318 | |
| GeneOntologyBiologicalProcess | neuron projection extension involved in neuron projection guidance | 5.28e-04 | 22 | 32 | 2 | GO:1902284 | |
| GeneOntologyBiologicalProcess | neural crest cell differentiation | 5.55e-04 | 104 | 32 | 3 | GO:0014033 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | 5.59e-04 | 1269 | 32 | 8 | GO:0009887 | |
| GeneOntologyBiologicalProcess | glomerular epithelium development | 5.78e-04 | 23 | 32 | 2 | GO:0072010 | |
| GeneOntologyBiologicalProcess | vasculature development | 5.92e-04 | 969 | 32 | 7 | GO:0001944 | |
| GeneOntologyBiologicalProcess | transcytosis | 6.30e-04 | 24 | 32 | 2 | GO:0045056 | |
| GeneOntologyBiologicalProcess | nephron tubule development | 6.54e-04 | 110 | 32 | 3 | GO:0072080 | |
| GeneOntologyBiologicalProcess | angiogenesis | 6.76e-04 | 708 | 32 | 6 | GO:0001525 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in visual perception | 6.84e-04 | 25 | 32 | 2 | GO:0050908 | |
| GeneOntologyBiologicalProcess | detection of light stimulus involved in sensory perception | 6.84e-04 | 25 | 32 | 2 | GO:0050962 | |
| GeneOntologyBiologicalProcess | positive regulation of Ras protein signal transduction | 6.84e-04 | 25 | 32 | 2 | GO:0046579 | |
| GeneOntologyBiologicalProcess | positive regulation of meiotic nuclear division | 7.40e-04 | 26 | 32 | 2 | GO:0045836 | |
| GeneOntologyBiologicalProcess | positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 7.44e-04 | 115 | 32 | 3 | GO:0090100 | |
| GeneOntologyBiologicalProcess | renal tubule development | 7.63e-04 | 116 | 32 | 3 | GO:0061326 | |
| GeneOntologyBiologicalProcess | atrioventricular valve morphogenesis | 8.60e-04 | 28 | 32 | 2 | GO:0003181 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 8.60e-04 | 28 | 32 | 2 | GO:0051152 | |
| GeneOntologyBiologicalProcess | response to abiotic stimulus | 8.88e-04 | 1361 | 32 | 8 | GO:0009628 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature development | 9.87e-04 | 30 | 32 | 2 | GO:0072012 | |
| GeneOntologyBiologicalProcess | nephron epithelium development | 1.02e-03 | 128 | 32 | 3 | GO:0072009 | |
| GeneOntologyBiologicalProcess | kidney vasculature development | 1.05e-03 | 31 | 32 | 2 | GO:0061440 | |
| GeneOntologyCellularComponent | receptor complex | 2.20e-04 | 581 | 32 | 6 | GO:0043235 | |
| GeneOntologyCellularComponent | clathrin-coated pit | 2.47e-04 | 80 | 32 | 3 | GO:0005905 | |
| Domain | EGF_CA | DNER LRP2 VLDLR THBS1 THBS2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 6.70e-17 | 122 | 32 | 11 | SM00179 |
| Domain | EGF-like_Ca-bd_dom | DNER LRP2 VLDLR THBS1 THBS2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 8.06e-17 | 124 | 32 | 11 | IPR001881 |
| Domain | EGF | DNER LRP2 VLDLR THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 9.66e-17 | 126 | 32 | 11 | PF00008 |
| Domain | EGF_3 | DNER LRP2 VLDLR THBS1 THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 2.15e-15 | 235 | 32 | 12 | PS50026 |
| Domain | EGF | DNER LRP2 VLDLR THBS1 THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 2.15e-15 | 235 | 32 | 12 | SM00181 |
| Domain | EGF-like_dom | DNER LRP2 VLDLR THBS1 THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 4.31e-15 | 249 | 32 | 12 | IPR000742 |
| Domain | EGF_1 | DNER LRP2 VLDLR THBS1 THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 5.74e-15 | 255 | 32 | 12 | PS00022 |
| Domain | EGF-like_CS | DNER LRP2 VLDLR THBS1 THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 7.59e-15 | 261 | 32 | 12 | IPR013032 |
| Domain | EGF_2 | DNER LRP2 VLDLR THBS1 THBS2 NTNG2 LRP1B F9 NOTCH1 NOTCH2 JAG1 SLIT3 | 9.11e-15 | 265 | 32 | 12 | PS01186 |
| Domain | EGF_Ca-bd_CS | 4.78e-14 | 97 | 32 | 9 | IPR018097 | |
| Domain | EGF_CA | 5.78e-14 | 99 | 32 | 9 | PS01187 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.09e-13 | 106 | 32 | 9 | IPR000152 | |
| Domain | EGF_CA | 1.39e-12 | 86 | 32 | 8 | PF07645 | |
| Domain | ASX_HYDROXYL | 4.80e-12 | 100 | 32 | 8 | PS00010 | |
| Domain | Growth_fac_rcpt_ | 1.75e-10 | 156 | 32 | 8 | IPR009030 | |
| Domain | EGF_extracell | 7.22e-10 | 60 | 32 | 6 | IPR013111 | |
| Domain | EGF_2 | 7.22e-10 | 60 | 32 | 6 | PF07974 | |
| Domain | hEGF | 1.41e-07 | 28 | 32 | 4 | PF12661 | |
| Domain | LDLR_class-A_CS | 6.21e-07 | 40 | 32 | 4 | IPR023415 | |
| Domain | Ldl_recept_a | 1.01e-06 | 45 | 32 | 4 | PF00057 | |
| Domain | - | 1.10e-06 | 46 | 32 | 4 | 4.10.400.10 | |
| Domain | LDLRA_1 | 1.31e-06 | 48 | 32 | 4 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 1.42e-06 | 49 | 32 | 4 | IPR002172 | |
| Domain | LDLa | 1.42e-06 | 49 | 32 | 4 | SM00192 | |
| Domain | LDLRA_2 | 1.42e-06 | 49 | 32 | 4 | PS50068 | |
| Domain | Ldl_recept_b | 1.64e-06 | 14 | 32 | 3 | PF00058 | |
| Domain | LDLRB | 1.64e-06 | 14 | 32 | 3 | PS51120 | |
| Domain | LY | 2.05e-06 | 15 | 32 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.05e-06 | 15 | 32 | 3 | IPR000033 | |
| Domain | TSP_1 | 3.94e-06 | 63 | 32 | 4 | PF00090 | |
| Domain | TSP1 | 4.46e-06 | 65 | 32 | 4 | SM00209 | |
| Domain | TSP1_rpt | 4.46e-06 | 65 | 32 | 4 | IPR000884 | |
| Domain | TSP1 | 4.46e-06 | 65 | 32 | 4 | PS50092 | |
| Domain | DUF3454 | 8.52e-06 | 3 | 32 | 2 | PF11936 | |
| Domain | DUF3454_notch | 8.52e-06 | 3 | 32 | 2 | IPR024600 | |
| Domain | DUF3454 | 8.52e-06 | 3 | 32 | 2 | SM01334 | |
| Domain | NOD | 1.70e-05 | 4 | 32 | 2 | PF06816 | |
| Domain | Notch | 1.70e-05 | 4 | 32 | 2 | IPR008297 | |
| Domain | NODP | 1.70e-05 | 4 | 32 | 2 | PF07684 | |
| Domain | Notch_NODP_dom | 1.70e-05 | 4 | 32 | 2 | IPR011656 | |
| Domain | Notch_NOD_dom | 1.70e-05 | 4 | 32 | 2 | IPR010660 | |
| Domain | NOD | 1.70e-05 | 4 | 32 | 2 | SM01338 | |
| Domain | NODP | 1.70e-05 | 4 | 32 | 2 | SM01339 | |
| Domain | LNR | 2.83e-05 | 5 | 32 | 2 | PS50258 | |
| Domain | TSP3 | 2.83e-05 | 5 | 32 | 2 | PS51234 | |
| Domain | TSP_CTER | 2.83e-05 | 5 | 32 | 2 | PS51236 | |
| Domain | - | 2.83e-05 | 5 | 32 | 2 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 2.83e-05 | 5 | 32 | 2 | IPR008859 | |
| Domain | TSP_C | 2.83e-05 | 5 | 32 | 2 | PF05735 | |
| Domain | Thrombospondin_3_rpt | 2.83e-05 | 5 | 32 | 2 | IPR017897 | |
| Domain | TSP_3 | 2.83e-05 | 5 | 32 | 2 | PF02412 | |
| Domain | Thrombospondin_3-like_rpt | 2.83e-05 | 5 | 32 | 2 | IPR003367 | |
| Domain | TSP_type-3_rpt | 2.83e-05 | 5 | 32 | 2 | IPR028974 | |
| Domain | VWC | 3.70e-05 | 38 | 32 | 3 | SM00214 | |
| Domain | - | 4.00e-05 | 39 | 32 | 3 | 2.120.10.30 | |
| Domain | VWF_dom | 5.01e-05 | 42 | 32 | 3 | IPR001007 | |
| Domain | Notch_dom | 5.94e-05 | 7 | 32 | 2 | IPR000800 | |
| Domain | Notch | 5.94e-05 | 7 | 32 | 2 | PF00066 | |
| Domain | NL | 5.94e-05 | 7 | 32 | 2 | SM00004 | |
| Domain | 6-blade_b-propeller_TolB-like | 6.60e-05 | 46 | 32 | 3 | IPR011042 | |
| Domain | SSXRD | 7.91e-05 | 8 | 32 | 2 | PF09514 | |
| Domain | SSXRD_motif | 7.91e-05 | 8 | 32 | 2 | IPR019041 | |
| Domain | Laminin_G | 1.32e-04 | 58 | 32 | 3 | IPR001791 | |
| Domain | KRAB_RELATED | 1.55e-04 | 11 | 32 | 2 | PS50806 | |
| Domain | Krueppel-associated_box-rel | 2.19e-04 | 13 | 32 | 2 | IPR003655 | |
| Domain | Semaphorin | 5.30e-04 | 20 | 32 | 2 | IPR027231 | |
| Domain | - | 5.68e-04 | 95 | 32 | 3 | 2.60.120.200 | |
| Domain | TSPN | 7.04e-04 | 23 | 32 | 2 | SM00210 | |
| Domain | cEGF | 9.01e-04 | 26 | 32 | 2 | IPR026823 | |
| Domain | cEGF | 9.01e-04 | 26 | 32 | 2 | PF12662 | |
| Domain | VWC | 1.05e-03 | 28 | 32 | 2 | PF00093 | |
| Domain | SEMA | 1.28e-03 | 31 | 32 | 2 | PS51004 | |
| Domain | Sema | 1.28e-03 | 31 | 32 | 2 | SM00630 | |
| Domain | Semap_dom | 1.28e-03 | 31 | 32 | 2 | IPR001627 | |
| Domain | Sema | 1.28e-03 | 31 | 32 | 2 | PF01403 | |
| Domain | Plexin_repeat | 1.37e-03 | 32 | 32 | 2 | IPR002165 | |
| Domain | PSI | 1.37e-03 | 32 | 32 | 2 | PF01437 | |
| Domain | VWFC_1 | 1.73e-03 | 36 | 32 | 2 | PS01208 | |
| Domain | VWFC_2 | 1.92e-03 | 38 | 32 | 2 | PS50184 | |
| Domain | PSI | 2.57e-03 | 44 | 32 | 2 | IPR016201 | |
| Domain | PSI | 2.81e-03 | 46 | 32 | 2 | SM00423 | |
| Domain | SET | 2.81e-03 | 46 | 32 | 2 | SM00317 | |
| Domain | SET_dom | 3.31e-03 | 50 | 32 | 2 | IPR001214 | |
| Domain | SET | 3.31e-03 | 50 | 32 | 2 | PS50280 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 4.38e-09 | 68 | 29 | 6 | M27303 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 2.45e-07 | 27 | 29 | 4 | M39545 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.84e-07 | 143 | 29 | 6 | M27275 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.13e-06 | 39 | 29 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.13e-06 | 39 | 29 | 4 | MM15165 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 1.70e-06 | 12 | 29 | 3 | M47532 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 2.21e-06 | 13 | 29 | 3 | M47423 | |
| Pathway | PID_NOTCH_PATHWAY | 6.08e-06 | 59 | 29 | 4 | M17 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 9.88e-06 | 250 | 29 | 6 | M27554 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 3.38e-05 | 31 | 29 | 3 | M592 | |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 4.07e-05 | 5 | 29 | 2 | M27411 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 6.10e-05 | 6 | 29 | 2 | M27068 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 6.92e-05 | 109 | 29 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 7.43e-05 | 111 | 29 | 4 | M27416 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_T_7_9_NOTCH1_M1580_K2555_TRANSLOCATION_MUTANT | 8.53e-05 | 7 | 29 | 2 | M27199 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.05e-04 | 45 | 29 | 3 | M39571 | |
| Pathway | WP_FATTY_ACIDS_AND_LIPOPROTEINS_TRANSPORT_IN_HEPATOCYTES | 1.05e-04 | 381 | 29 | 6 | M48063 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.12e-04 | 46 | 29 | 3 | MM15971 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.19e-04 | 47 | 29 | 3 | M7946 | |
| Pathway | WP_NEUROGENESIS_REGULATION_IN_THE_OLFACTORY_EPITHELIUM | 2.13e-04 | 57 | 29 | 3 | M48326 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.22e-04 | 11 | 29 | 2 | M47865 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 2.60e-04 | 61 | 29 | 3 | M39540 | |
| Pathway | BIOCARTA_HES_PATHWAY | 2.66e-04 | 12 | 29 | 2 | MM1562 | |
| Pathway | BIOCARTA_HES_PATHWAY | 2.66e-04 | 12 | 29 | 2 | M22042 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 2.66e-04 | 12 | 29 | 2 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 3.14e-04 | 13 | 29 | 2 | M47534 | |
| Pathway | REACTOME_RUNX3_REGULATES_NOTCH_SIGNALING | 3.66e-04 | 14 | 29 | 2 | M27808 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 4.22e-04 | 15 | 29 | 2 | M27202 | |
| Pathway | WP_AXON_GUIDANCE | 4.24e-04 | 72 | 29 | 3 | M48335 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1 | 4.60e-04 | 74 | 29 | 3 | M616 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 4.72e-04 | 1475 | 29 | 10 | M19806 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 4.82e-04 | 16 | 29 | 2 | M47424 | |
| Pathway | WP_AMPLIFICATION_AND_EXPANSION_OF_ONCOGENIC_PATHWAYS_AS_METASTATIC_TRAITS | 5.45e-04 | 17 | 29 | 2 | M39443 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 5.45e-04 | 17 | 29 | 2 | M39389 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 6.13e-04 | 18 | 29 | 2 | M614 | |
| Pathway | WP_NEPHROGENESIS | 6.13e-04 | 18 | 29 | 2 | M40045 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH4 | 6.21e-04 | 82 | 29 | 3 | M594 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 6.21e-04 | 82 | 29 | 3 | MM15922 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 7.59e-04 | 20 | 29 | 2 | M27881 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 9.20e-04 | 22 | 29 | 2 | M27210 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 1.10e-03 | 24 | 29 | 2 | M11190 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 1.49e-03 | 28 | 29 | 2 | M6177 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.52e-03 | 246 | 29 | 4 | M10189 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 1.78e-03 | 118 | 29 | 3 | M39852 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 2.07e-03 | 33 | 29 | 2 | M277 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 2.07e-03 | 33 | 29 | 2 | M604 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 2.20e-03 | 34 | 29 | 2 | M39390 | |
| Pathway | KEGG_AXON_GUIDANCE | 2.30e-03 | 129 | 29 | 3 | M5539 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 2.60e-03 | 37 | 29 | 2 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.89e-03 | 39 | 29 | 2 | MM14604 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.50e-03 | 43 | 29 | 2 | M39565 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 3.83e-03 | 45 | 29 | 2 | MM15344 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 4.30e-03 | 161 | 29 | 3 | M39770 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 4.35e-03 | 48 | 29 | 2 | M27642 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 4.53e-03 | 49 | 29 | 2 | M618 | |
| Pathway | WP_PRIMARY_OVARIAN_INSUFFICIENCY | 5.33e-03 | 174 | 29 | 3 | M48058 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | 5.66e-03 | 1389 | 29 | 8 | MM15307 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.08e-03 | 57 | 29 | 2 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 6.29e-03 | 58 | 29 | 2 | M2049 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_PEST_DOMAIN_MUTANTS_IN_CANCER | 6.29e-03 | 58 | 29 | 2 | M29616 | |
| Pathway | WP_MARKERS_OF_KIDNEY_CELL_LINEAGE | 6.50e-03 | 59 | 29 | 2 | M46460 | |
| Pathway | WP_DYRK1A_INVOLVEMENT_REGARDING_CELL_PROLIFERATION_IN_BRAIN_DEVELOPMENT | 7.16e-03 | 62 | 29 | 2 | M45532 | |
| Pubmed | 7.07e-10 | 3 | 32 | 3 | 18032585 | ||
| Pubmed | Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells. | 7.07e-10 | 3 | 32 | 3 | 14726396 | |
| Pubmed | 2.26e-09 | 19 | 32 | 4 | 25691540 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 19147503 | ||
| Pubmed | Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes. | 2.83e-09 | 4 | 32 | 3 | 22390640 | |
| Pubmed | Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated metabolic reprogramming. | 2.83e-09 | 4 | 32 | 3 | 30226866 | |
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 10551863 | ||
| Pubmed | 2.83e-09 | 4 | 32 | 3 | 24398584 | ||
| Pubmed | Functional diversity of notch family genes in fetal lung development. | 7.07e-09 | 5 | 32 | 3 | 15064243 | |
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 11713346 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 15882997 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 27118257 | ||
| Pubmed | 7.07e-09 | 5 | 32 | 3 | 35064244 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 10958687 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 1.41e-08 | 6 | 32 | 3 | 12244553 | |
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 22526456 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 15226394 | ||
| Pubmed | Interaction between Reelin and Notch signaling regulates neuronal migration in the cerebral cortex. | 1.41e-08 | 6 | 32 | 3 | 18957219 | |
| Pubmed | Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura. | 1.41e-08 | 6 | 32 | 3 | 19603167 | |
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 9108364 | ||
| Pubmed | 1.41e-08 | 6 | 32 | 3 | 31071093 | ||
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 10383933 | ||
| Pubmed | 2.47e-08 | 7 | 32 | 3 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 2.47e-08 | 7 | 32 | 3 | 12846471 | |
| Pubmed | Differentiation of CD11c+ CX3CR1+ cells in the small intestine requires Notch signaling. | 2.47e-08 | 7 | 32 | 3 | 24711412 | |
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 3.54e-08 | 101 | 32 | 5 | 23382219 | |
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 19914235 | ||
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 22156581 | ||
| Pubmed | P4 down-regulates Jagged2 and Notch1 expression during primordial folliculogenesis. | 3.95e-08 | 8 | 32 | 3 | 22652674 | |
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 3.95e-08 | 8 | 32 | 3 | 12242716 | |
| Pubmed | Expression of Hairy/Enhancer of Split genes, Hes1 and Hes5, during murine nephron morphogenesis. | 3.95e-08 | 8 | 32 | 3 | 15465493 | |
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 9858718 | ||
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 15068794 | ||
| Pubmed | 3.95e-08 | 8 | 32 | 3 | 11044610 | ||
| Pubmed | 5.27e-08 | 40 | 32 | 4 | 23362348 | ||
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 11118901 | ||
| Pubmed | 5.92e-08 | 9 | 32 | 3 | 16245338 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 8.45e-08 | 10 | 32 | 3 | 23665443 | |
| Pubmed | 8.45e-08 | 10 | 32 | 3 | 24015274 | ||
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 1.16e-07 | 11 | 32 | 3 | 15499562 | |
| Pubmed | 1.16e-07 | 11 | 32 | 3 | 10878608 | ||
| Pubmed | Defects in somite formation in lunatic fringe-deficient mice. | 1.16e-07 | 11 | 32 | 3 | 9690472 | |
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 1.16e-07 | 11 | 32 | 3 | 9187150 | |
| Pubmed | 1.16e-07 | 11 | 32 | 3 | 12866128 | ||
| Pubmed | Notch signaling promotes nephrogenesis by downregulating Six2. | 1.55e-07 | 12 | 32 | 3 | 27633993 | |
| Pubmed | 1.55e-07 | 12 | 32 | 3 | 15465494 | ||
| Pubmed | 1.55e-07 | 12 | 32 | 3 | 32147304 | ||
| Pubmed | 1.55e-07 | 12 | 32 | 3 | 14732396 | ||
| Pubmed | 1.55e-07 | 12 | 32 | 3 | 17572911 | ||
| Pubmed | Node and midline defects are associated with left-right development in Delta1 mutant embryos. | 2.01e-07 | 13 | 32 | 3 | 12441287 | |
| Pubmed | Jagged1 is Essential for Radial Glial Maintenance in the Cortical Proliferative Zone. | 2.01e-07 | 13 | 32 | 3 | 31202705 | |
| Pubmed | Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. | 2.01e-07 | 13 | 32 | 3 | 11578869 | |
| Pubmed | Inhibition of notch1-dependent cardiomyogenesis leads to a dilated myopathy in the neonatal heart. | 2.01e-07 | 13 | 32 | 3 | 20558824 | |
| Pubmed | 2.56e-07 | 14 | 32 | 3 | 23806616 | ||
| Pubmed | 2.56e-07 | 14 | 32 | 3 | 15082773 | ||
| Pubmed | 2.56e-07 | 14 | 32 | 3 | 14757642 | ||
| Pubmed | 2.59e-07 | 59 | 32 | 4 | 21421844 | ||
| Pubmed | 3.19e-07 | 15 | 32 | 3 | 12971992 | ||
| Pubmed | Lunatic fringe, FGF, and BMP regulate the Notch pathway during epithelial morphogenesis of teeth. | 3.19e-07 | 15 | 32 | 3 | 12167404 | |
| Pubmed | COUP-TFI controls Notch regulation of hair cell and support cell differentiation. | 3.19e-07 | 15 | 32 | 3 | 16914494 | |
| Pubmed | Expression of Notch pathway components in fetal and adult mouse small intestine. | 3.93e-07 | 16 | 32 | 3 | 12617809 | |
| Pubmed | Notch2, but not Notch1, is required for proximal fate acquisition in the mammalian nephron. | 3.93e-07 | 16 | 32 | 3 | 17229764 | |
| Pubmed | 3.93e-07 | 16 | 32 | 3 | 10842072 | ||
| Pubmed | 3.93e-07 | 16 | 32 | 3 | 17273555 | ||
| Pubmed | The Cellular Prion Protein Controls Notch Signaling in Neural Stem/Progenitor Cells. | 3.93e-07 | 16 | 32 | 3 | 27641601 | |
| Pubmed | 3.93e-07 | 16 | 32 | 3 | 20007915 | ||
| Pubmed | Sall4 regulates cell fate decision in fetal hepatic stem/progenitor cells. | 3.93e-07 | 16 | 32 | 3 | 19185577 | |
| Pubmed | 3.93e-07 | 16 | 32 | 3 | 32161758 | ||
| Pubmed | 4.77e-07 | 17 | 32 | 3 | 18694942 | ||
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 4.77e-07 | 17 | 32 | 3 | 15821257 | |
| Pubmed | Presenilin gene function and Notch signaling feedback regulation in the developing mouse lens. | 4.77e-07 | 17 | 32 | 3 | 30059908 | |
| Pubmed | 4.77e-07 | 17 | 32 | 3 | 10476967 | ||
| Pubmed | 5.49e-07 | 71 | 32 | 4 | 33541421 | ||
| Pubmed | Notch Signaling Pathway in Tooth Shape Variations throughout Evolution. | 5.72e-07 | 18 | 32 | 3 | 36899896 | |
| Pubmed | 5.72e-07 | 18 | 32 | 3 | 18093989 | ||
| Pubmed | Negative regulation of endothelin signaling by SIX1 is required for proper maxillary development. | 5.72e-07 | 18 | 32 | 3 | 28455376 | |
| Pubmed | 5.72e-07 | 18 | 32 | 3 | 15689374 | ||
| Pubmed | 5.72e-07 | 18 | 32 | 3 | 29113990 | ||
| Pubmed | 6.79e-07 | 19 | 32 | 3 | 21302255 | ||
| Pubmed | 6.79e-07 | 19 | 32 | 3 | 20335360 | ||
| Pubmed | 6.79e-07 | 19 | 32 | 3 | 16518823 | ||
| Pubmed | Generation of Distal Renal Segments Involves a Unique Population of Aqp2 + Progenitor Cells. | 6.79e-07 | 19 | 32 | 3 | 34667084 | |
| Pubmed | 6.79e-07 | 19 | 32 | 3 | 22675211 | ||
| Pubmed | 6.85e-07 | 75 | 32 | 4 | 20637190 | ||
| Pubmed | Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. | 7.98e-07 | 20 | 32 | 3 | 23314057 | |
| Pubmed | Evolution of Cortical Neurogenesis in Amniotes Controlled by Robo Signaling Levels. | 7.98e-07 | 20 | 32 | 3 | 29961574 | |
| Pubmed | Up-regulated expression of Notch1 and Jagged1 in human colon adenocarcinoma. | 8.20e-07 | 2 | 32 | 2 | 21145176 | |
| Pubmed | A role for notch signaling in human corneal epithelial cell differentiation and proliferation. | 8.20e-07 | 2 | 32 | 2 | 17652726 | |
| Pubmed | Induced thrombospondin expression in the mouse pancreas during pancreatic injury. | 8.20e-07 | 2 | 32 | 2 | 16181801 | |
| Pubmed | Notch1 and Notch2 expression in osteoblast precursors regulates femoral microarchitecture. | 8.20e-07 | 2 | 32 | 2 | 24508387 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 17620335 | ||
| Pubmed | Clinical role of Notch signaling pathway in intraductal papillary mucinous neoplasm of the pancreas. | 8.20e-07 | 2 | 32 | 2 | 25041344 | |
| Pubmed | Notch controls generation and function of human effector CD8+ T cells. | 8.20e-07 | 2 | 32 | 2 | 23380742 | |
| Pubmed | Human cytomegalovirus infection modulates thrombospondins 1 and 2 in primary fetal astrocytes. | 8.20e-07 | 2 | 32 | 2 | 23660684 | |
| Pubmed | Endothelium and NOTCH specify and amplify aorta-gonad-mesonephros-derived hematopoietic stem cells. | 8.20e-07 | 2 | 32 | 2 | 25866967 | |
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 32423029 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 39122122 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 29708032 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 21466361 | ||
| Pubmed | 8.20e-07 | 2 | 32 | 2 | 34425286 | ||
| Interaction | IGFL3 interactions | 1.82e-09 | 75 | 32 | 6 | int:IGFL3 | |
| Interaction | NTN5 interactions | 5.44e-08 | 24 | 32 | 4 | int:NTN5 | |
| Interaction | JAG1 interactions | 5.09e-07 | 41 | 32 | 4 | int:JAG1 | |
| Interaction | SEC61B interactions | 1.95e-06 | 763 | 32 | 9 | int:SEC61B | |
| Interaction | THBS2 interactions | 3.46e-06 | 19 | 32 | 3 | int:THBS2 | |
| Interaction | MFNG interactions | 1.04e-05 | 27 | 32 | 3 | int:MFNG | |
| Interaction | DYRK1A interactions | 2.07e-05 | 552 | 32 | 7 | int:DYRK1A | |
| Interaction | DLK2 interactions | 2.51e-05 | 36 | 32 | 3 | int:DLK2 | |
| Interaction | JAG2 interactions | 2.69e-05 | 110 | 32 | 4 | int:JAG2 | |
| Interaction | ZDHHC15 interactions | 4.43e-05 | 125 | 32 | 4 | int:ZDHHC15 | |
| Interaction | NOTCH2 interactions | 4.71e-05 | 423 | 32 | 6 | int:NOTCH2 | |
| Interaction | THBS1 interactions | 4.72e-05 | 127 | 32 | 4 | int:THBS1 | |
| Interaction | DKK2 interactions | 6.38e-05 | 49 | 32 | 3 | int:DKK2 | |
| Interaction | FOXD4L6 interactions | 6.38e-05 | 49 | 32 | 3 | int:FOXD4L6 | |
| Interaction | DNER interactions | 6.80e-05 | 8 | 32 | 2 | int:DNER | |
| Interaction | ZNF408 interactions | 7.90e-05 | 145 | 32 | 4 | int:ZNF408 | |
| Interaction | LRP2 interactions | 9.98e-05 | 154 | 32 | 4 | int:LRP2 | |
| Interaction | ZFP41 interactions | 1.00e-04 | 57 | 32 | 3 | int:ZFP41 | |
| Interaction | ANKRD36B interactions | 1.17e-04 | 60 | 32 | 3 | int:ANKRD36B | |
| Interaction | SLIT3 interactions | 1.33e-04 | 11 | 32 | 2 | int:SLIT3 | |
| Interaction | FBN2 interactions | 1.49e-04 | 65 | 32 | 3 | int:FBN2 | |
| Interaction | ZNF611 interactions | 1.60e-04 | 12 | 32 | 2 | int:ZNF611 | |
| Interaction | LGALS1 interactions | 1.64e-04 | 332 | 32 | 5 | int:LGALS1 | |
| Interaction | RNASE4 interactions | 2.20e-04 | 14 | 32 | 2 | int:RNASE4 | |
| Interaction | IGSF5 interactions | 2.20e-04 | 14 | 32 | 2 | int:IGSF5 | |
| Interaction | TG interactions | 2.20e-04 | 14 | 32 | 2 | int:TG | |
| Interaction | LFNG interactions | 2.20e-04 | 14 | 32 | 2 | int:LFNG | |
| Interaction | APBB1 interactions | 2.47e-04 | 195 | 32 | 4 | int:APBB1 | |
| Interaction | SEMA5B interactions | 2.53e-04 | 15 | 32 | 2 | int:SEMA5B | |
| Interaction | TRIM66 interactions | 2.99e-04 | 205 | 32 | 4 | int:TRIM66 | |
| Interaction | MAML2 interactions | 3.27e-04 | 17 | 32 | 2 | int:MAML2 | |
| Interaction | TIMP3 interactions | 3.89e-04 | 90 | 32 | 3 | int:TIMP3 | |
| Interaction | MDK interactions | 4.02e-04 | 91 | 32 | 3 | int:MDK | |
| Interaction | CCN6 interactions | 4.11e-04 | 19 | 32 | 2 | int:CCN6 | |
| Interaction | FBXO2 interactions | 4.40e-04 | 411 | 32 | 5 | int:FBXO2 | |
| Interaction | MAML3 interactions | 4.56e-04 | 20 | 32 | 2 | int:MAML3 | |
| Interaction | ZNF224 interactions | 4.56e-04 | 20 | 32 | 2 | int:ZNF224 | |
| Interaction | EGFL6 interactions | 5.03e-04 | 21 | 32 | 2 | int:EGFL6 | |
| Interaction | CASR interactions | 5.53e-04 | 22 | 32 | 2 | int:CASR | |
| Interaction | DTX4 interactions | 5.53e-04 | 22 | 32 | 2 | int:DTX4 | |
| Interaction | WNT2 interactions | 6.05e-04 | 23 | 32 | 2 | int:WNT2 | |
| Interaction | SYT1 interactions | 6.11e-04 | 105 | 32 | 3 | int:SYT1 | |
| Interaction | DAB1 interactions | 6.45e-04 | 107 | 32 | 3 | int:DAB1 | |
| Interaction | LRP5 interactions | 6.81e-04 | 109 | 32 | 3 | int:LRP5 | |
| Interaction | NOTCH3 interactions | 7.56e-04 | 113 | 32 | 3 | int:NOTCH3 | |
| Interaction | TMEM268 interactions | 8.36e-04 | 27 | 32 | 2 | int:TMEM268 | |
| Interaction | TNFAIP6 interactions | 8.36e-04 | 27 | 32 | 2 | int:TNFAIP6 | |
| Interaction | SULF2 interactions | 8.79e-04 | 119 | 32 | 3 | int:SULF2 | |
| Interaction | FEZF1 interactions | 9.00e-04 | 28 | 32 | 2 | int:FEZF1 | |
| Interaction | PLXNA4 interactions | 9.00e-04 | 28 | 32 | 2 | int:PLXNA4 | |
| Interaction | ZNF517 interactions | 9.65e-04 | 29 | 32 | 2 | int:ZNF517 | |
| Interaction | GLI4 interactions | 1.01e-03 | 125 | 32 | 3 | int:GLI4 | |
| Interaction | CFC1 interactions | 1.04e-03 | 126 | 32 | 3 | int:CFC1 | |
| Cytoband | 2q21.2 | 4.26e-05 | 14 | 32 | 2 | 2q21.2 | |
| GeneFamily | Low density lipoprotein receptors | 9.55e-10 | 13 | 21 | 4 | 634 | |
| GeneFamily | Zinc fingers C2H2-type|PR/SET domain family | 1.73e-04 | 17 | 21 | 2 | 1197 | |
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 2.41e-04 | 20 | 21 | 2 | 736 | |
| GeneFamily | PHD finger proteins | 4.84e-03 | 90 | 21 | 2 | 88 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 9.22e-08 | 8 | 32 | 3 | M9884 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 9.16e-07 | 16 | 32 | 3 | M2207 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 9.16e-07 | 16 | 32 | 3 | MM1296 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.35e-06 | 191 | 32 | 5 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.80e-06 | 196 | 32 | 5 | M3008 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 6.51e-06 | 600 | 32 | 7 | M39055 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 8.00e-06 | 32 | 32 | 3 | M5903 | |
| Coexpression | NABA_CORE_MATRISOME | 1.79e-05 | 270 | 32 | 5 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 1.96e-05 | 275 | 32 | 5 | M5884 | |
| Coexpression | NABA_MATRISOME | 2.15e-05 | 1008 | 32 | 8 | MM17056 | |
| Coexpression | NABA_MATRISOME | 2.44e-05 | 1026 | 32 | 8 | M5889 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 7.40e-05 | 185 | 32 | 4 | M42503 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C4 | 7.89e-05 | 11 | 32 | 2 | M566 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BONE_METASTASIS | 7.89e-05 | 11 | 32 | 2 | M47997 | |
| Coexpression | WU_APOPTOSIS_BY_CDKN1A_NOT_VIA_TP53 | 7.89e-05 | 11 | 32 | 2 | M6312 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 8.55e-05 | 192 | 32 | 4 | M42501 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.00e-04 | 200 | 32 | 4 | M5930 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2B | 1.79e-04 | 439 | 32 | 5 | M39054 | |
| Coexpression | MOREIRA_RESPONSE_TO_TSA_DN | 2.18e-04 | 18 | 32 | 2 | M3506 | |
| Coexpression | BENPORATH_SOX2_TARGETS | 2.30e-04 | 734 | 32 | 6 | M3835 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.67e-04 | 479 | 32 | 5 | M2573 | |
| Coexpression | BRAUNE_GEIST_20_GENE_NOTCH_SIG_BREAST_CANCER | 2.71e-04 | 20 | 32 | 2 | M48357 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.77e-04 | 261 | 32 | 4 | M1834 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.78e-04 | 483 | 32 | 5 | MM1082 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 | 3.09e-04 | 108 | 32 | 3 | M1281 | |
| Coexpression | CLIMENT_BREAST_CANCER_COPY_NUMBER_UP | 3.60e-04 | 23 | 32 | 2 | M13910 | |
| Coexpression | SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5 | 4.01e-04 | 118 | 32 | 3 | MM536 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 4.21e-04 | 120 | 32 | 3 | M42505 | |
| Coexpression | LU_TUMOR_ANGIOGENESIS_UP | 4.26e-04 | 25 | 32 | 2 | M9946 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_VASCULAR_SMC_1_CELL | 4.64e-04 | 124 | 32 | 3 | M45686 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_DN | 5.94e-04 | 135 | 32 | 3 | M5825 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 6.15e-04 | 30 | 32 | 2 | M47990 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2C | 6.34e-04 | 325 | 32 | 4 | M39053 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 2.50e-05 | 398 | 32 | 6 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 5.35e-05 | 456 | 32 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 1.54e-04 | 799 | 32 | 7 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | EB blastocyst_vs_EB bone marrow-Confounder_removed-fold2.0_adjp0.05 | 1.54e-04 | 345 | 32 | 5 | PCBC_ratio_EB blastocyst_vs_EB bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | 1.68e-04 | 1094 | 32 | 8 | ratio_EB_vs_SC_2500_K3 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_1000 | 2.03e-04 | 836 | 32 | 7 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_1000 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 2.89e-04 | 395 | 32 | 5 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_top-relative-expression-ranked_100 | 2.92e-04 | 86 | 32 | 3 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Pelvic Mesenchyme_emap-8241_k-means-cluster#2_top-relative-expression-ranked_100 | 2.95e-04 | 17 | 32 | 2 | gudmap_developingKidney_e15.5_Pelvic Mesenchyme_100_k2 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 3.21e-04 | 404 | 32 | 5 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | 3.30e-04 | 905 | 32 | 7 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 4.45e-04 | 951 | 32 | 7 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 4.99e-04 | 445 | 32 | 5 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_k-means-cluster#3_top-relative-expression-ranked_500 | 5.13e-04 | 249 | 32 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle F_500_k3 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 5.41e-04 | 453 | 32 | 5 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 5.52e-04 | 455 | 32 | 5 | GSM777055_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | 5.53e-04 | 986 | 32 | 7 | PCBC_EB_fibroblast_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_top-relative-expression-ranked_1000 | 5.80e-04 | 994 | 32 | 7 | PCBC_EB_1000 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.10e-07 | 186 | 32 | 5 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 2.16e-07 | 187 | 32 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.28e-07 | 189 | 32 | 5 | d0c7549be4f77520c23dddf4f94d0fcad0081e37 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 2.40e-07 | 191 | 32 | 5 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-07 | 193 | 32 | 5 | 47d189bac0ef4df2f5c6dd987e46aca85bd7e2af | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.52e-06 | 155 | 32 | 4 | 3b8def9e8f66511736ea37f259511f7c8b7743af | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.67e-06 | 171 | 32 | 4 | 4ede831aed364cb5271f49a8b09bb6d0452f9b35 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.67e-06 | 171 | 32 | 4 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.14e-06 | 174 | 32 | 4 | 015d3742d3d79a57413a333f00ef2d380a9848dd | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.81e-06 | 178 | 32 | 4 | 066dbc4cc2083c549d98122ed44707127f34d582 | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 8.71e-06 | 183 | 32 | 4 | b4f29dd3994009bb5eb769d36d95886664e7f87d | |
| ToppCell | 5'-GW_trimst-2-LymphNode-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.90e-06 | 184 | 32 | 4 | 4d4d8f3f44c67d74c57e7af7b7c158f0157b2f49 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-06 | 186 | 32 | 4 | 0b2ce9b8a4382d583240647217ad5e2d3fa555c1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 186 | 32 | 4 | 4780af76237d7af2abbe2d8d5530cdf53e3ed0b7 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-06 | 186 | 32 | 4 | db4d9ac89cc1e55062ba888b3410b773340595dd | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.29e-06 | 186 | 32 | 4 | a95744b8649096bd7cfc3591a02841fa411085b3 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.29e-06 | 186 | 32 | 4 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 9.49e-06 | 187 | 32 | 4 | 1aebf6fab40b96f2f5feb77a302bb805838fccf3 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.49e-06 | 187 | 32 | 4 | d52f7bc0afcdc366b20d199ab33c4ec60ed22a68 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-Pericytes-angiogenic_pericyte|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.69e-06 | 188 | 32 | 4 | 0a5b93c131ce8514e996b0c2f39e0fc98636c122 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_pericyte_(14)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 9.89e-06 | 189 | 32 | 4 | 9c2492c38f27e4c699b40680652e4c64911cce52 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.89e-06 | 189 | 32 | 4 | e9d5e858e320c6e9913c1ea6a54967d21eda605f | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 32 | 4 | 7df63e5e0dd395676f4fc18cad0d8b2428390943 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.01e-05 | 190 | 32 | 4 | a7f6c38bbf451f166febb21e6719d4afced4035e | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 32 | 4 | 73d94fbae92029745989a8712eed8b99fd84c193 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.01e-05 | 190 | 32 | 4 | d6b3a92119b210974a32af3fe9875d60eb02761e | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.01e-05 | 190 | 32 | 4 | 140aca04c044cd7a93f81ff1631b00b5216d2cb1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 190 | 32 | 4 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 32 | 4 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.01e-05 | 190 | 32 | 4 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.03e-05 | 191 | 32 | 4 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 191 | 32 | 4 | 9f478f36a0b895e607e3bb77fa0f9f03cc0f33fc | |
| ToppCell | Mesenchymal-vascular_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 1.03e-05 | 191 | 32 | 4 | fd89fbc62aa1c73e0f659991e3bd726a0c97bd68 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.03e-05 | 191 | 32 | 4 | 239c1e68eb1cbe3e137a99fbd6eeb8d64c919ffd | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 192 | 32 | 4 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-05 | 192 | 32 | 4 | dee97f650ae6f4d07a142ade402aae1905791a22 | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.05e-05 | 192 | 32 | 4 | a7d08416f07f29ad920168a3b52ddf992f263bf4 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 192 | 32 | 4 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.05e-05 | 192 | 32 | 4 | ee085e04d5dcfb657522484ed20b8c1ddeccfe0c | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_myocytic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 32 | 4 | 000b9e6a819b94ea2e6e9173daf97ba9ac2b6cc6 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.07e-05 | 193 | 32 | 4 | 261cafc167c86ab277be4ea7f08b0173e2dde26e | |
| ToppCell | wk_20-22-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.07e-05 | 193 | 32 | 4 | ba6eb29478d16589172f48f9992e5116328c81d6 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-05 | 193 | 32 | 4 | 051f61156b0e2e95292b2d8377faf3190b50f264 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-2M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type. | 1.10e-05 | 194 | 32 | 4 | 7c6c0376603e5fcb64814fd6204d153629c2fbf5 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes-Immature_pericyte|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.10e-05 | 194 | 32 | 4 | 7a7406c3b021aeafde423d20290c681c3e8ea0a6 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.10e-05 | 194 | 32 | 4 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | 18-Distal-Mesenchymal-Pericyte|Distal / Age, Tissue, Lineage and Cell class | 1.12e-05 | 195 | 32 | 4 | e0ee7905499ee1a1ca7b1184e2713028cf156985 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 195 | 32 | 4 | fc43cd295f2cc3f6e9442232e028944f011c82cc | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-Pericytes|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.12e-05 | 195 | 32 | 4 | 9b3fa1d42ec5aa2911f27a99cd8b57714c6bd604 | |
| ToppCell | wk_15-18-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_1|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 196 | 32 | 4 | 40cae477b3906623d1f2a4c630279e710499ce80 | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-Adventitial_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.14e-05 | 196 | 32 | 4 | eed9fe83ffc1f79493b70778962a671dd9f481e0 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG-25|World / Primary Cells by Cluster | 1.16e-05 | 197 | 32 | 4 | 9d4ffa3680f92c91d0a081f9a8ec5ebfec6bdcf6 | |
| ToppCell | Non-neuronal-Non-dividing-Radial_Glia-tRG|World / Primary Cells by Cluster | 1.16e-05 | 197 | 32 | 4 | 61749ccafeb938c310cff1de5ff924a1c794325a | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-05 | 197 | 32 | 4 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-Pericytes-Pericyte|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | 452be45f4aac8459dd860493171f5f715368d663 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | 7c275a2ac24a9a4f83fceda93a067e754837102f | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-05 | 197 | 32 | 4 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.16e-05 | 197 | 32 | 4 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.16e-05 | 197 | 32 | 4 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.19e-05 | 198 | 32 | 4 | be305d89d48c67ce922fa71aaf15e24d00c89ff6 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Adventitial_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.21e-05 | 199 | 32 | 4 | 8de6d7b2067b22cb9b5f01aa56a3803aebc4406d | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_systemic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 32 | 4 | 78a9b26215874a46a910a4b93a51fcac1a597618 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO---L5-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 7b845aabfbdfe893acc9334a5707833761bed60b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | e3051dcf9b5c8e4dc71a8080b7a7aafea46f2b2b | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 0638273fc0910f47fe7a0b6d9a8639b0e9976d13 | |
| ToppCell | Neuronal-Excitatory-eD(FEZF2)-ABO--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 1.24e-05 | 200 | 32 | 4 | 1ce9599cc9d8158e8842ca56f35fa7809c234849 | |
| ToppCell | Control-Neutrophil|Control / Disease condition and Cell class | 1.00e-04 | 126 | 32 | 3 | 450c01d89714feee6529680ec3ce69067a54b37c | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.00e-04 | 126 | 32 | 3 | 730fc6dc740613b55e40e85334fa30330aa81c3b | |
| ToppCell | Control-Neutrophil-|Control / Disease condition and Cell class | 1.00e-04 | 126 | 32 | 3 | 65fff5ec2296272e94f44546606587833191dd82 | |
| ToppCell | Control-Myeloid_G-Neutrophil|Control / Disease group, lineage and cell class | 1.03e-04 | 127 | 32 | 3 | d4af23d621b546785a077c367c3a66c59749fc15 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.05e-04 | 128 | 32 | 3 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.05e-04 | 128 | 32 | 3 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.10e-04 | 130 | 32 | 3 | cd6d8d646345b01ff0f04f776330a05b82e63bc9 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 142 | 32 | 3 | a05b320cf182b2aaf18df7c40045dc65b659bf20 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Epi-like-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.43e-04 | 142 | 32 | 3 | d52da766e031f7409eb5a7a9fa88f48e14a79d8b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.85e-04 | 155 | 32 | 3 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.92e-04 | 157 | 32 | 3 | c779a53b2c67d566f5d417e753cd17196a6bfd1c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.96e-04 | 158 | 32 | 3 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.96e-04 | 158 | 32 | 3 | 84c0a215dabf697ada036c2b9592d0c61b5077de | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D122|Adult / Lineage, Cell type, age group and donor | 2.03e-04 | 160 | 32 | 3 | fd14dfeb7021a4b7299371854dc8fc1fd66c8dae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 161 | 32 | 3 | a7e09cf2ca6cd70d40d08440fe9c5ab9befa1b79 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 161 | 32 | 3 | 08920a716f6ec62538e361211455a30ad726d7be | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-04 | 161 | 32 | 3 | 1f4614ae15bd2fc08e555cea4d0152c4a940d048 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_D3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.07e-04 | 161 | 32 | 3 | 3e5a125a25d55bf27652f456239b00b315d54d91 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-vascular_smooth_muscle_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.14e-04 | 163 | 32 | 3 | 51dee6c21cbeca4e17d1cc386e203f0c403089e8 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Lsp1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.14e-04 | 163 | 32 | 3 | bba830a302919c8b33f914a8839877fc21dd28a0 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Lamp5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.18e-04 | 164 | 32 | 3 | 08819970174a3eb4eee8e1e675075828665b845e | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.18e-04 | 164 | 32 | 3 | f9a2cc12179d5621c9174ec01d7418a71edd28d1 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 32 | 3 | cd8de98af8a1a8a6c81d71fae807cc07f319f4c9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-04 | 165 | 32 | 3 | 4f83ac71efc57be3668d8db1e62bad05dc6a5e2b | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 166 | 32 | 3 | 7c2eee0a4f45795a956acf936b85bdb35f1b1624 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.26e-04 | 166 | 32 | 3 | 7286a37b2827f3747469ffd0d76cbe81116db7ee | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-04 | 167 | 32 | 3 | 805129f887078340b260aa136b0ba19f2bd6ea03 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-04 | 167 | 32 | 3 | 31cf8bf2eb523f6e7e319620648ff37fc09e2601 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.30e-04 | 167 | 32 | 3 | 3acb18428d1d33ad430c2fd031b1a91baee3c01d | |
| ToppCell | COVID-19-kidney-PEC|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-04 | 168 | 32 | 3 | a086c306be430adf0632ba53e98cd8014d2de330 | |
| ToppCell | droplet-Heart-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-04 | 169 | 32 | 3 | 2e5bb6437bc9c614e337c5ffb6f6457cd9fc7f4c | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like_Prolif-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.38e-04 | 169 | 32 | 3 | 2833a8a7094e4d407eb923f2bc59b9b112c6bae4 | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 8.26e-06 | 200 | 32 | 5 | 6450_UP | |
| Drug | monatepil | 8.99e-06 | 29 | 32 | 3 | CID000060810 | |
| Drug | glycovir | 1.15e-05 | 4 | 32 | 2 | CID000060807 | |
| Drug | vs 261 | 1.15e-05 | 4 | 32 | 2 | CID000380111 | |
| Drug | basic brown 1 | 1.15e-05 | 4 | 32 | 2 | CID000013981 | |
| Drug | sodium cholate | 1.95e-05 | 408 | 32 | 6 | CID000000303 | |
| Drug | Chr 5 | 2.76e-05 | 125 | 32 | 4 | CID006448119 | |
| Drug | beidellite | 2.86e-05 | 6 | 32 | 2 | CID006367228 | |
| Drug | PMDETA | 2.86e-05 | 6 | 32 | 2 | CID000018196 | |
| Drug | N-(N-(3,5-difluorophenacetyl)alanyl)phenylglycine tert-butyl ester | 3.21e-05 | 44 | 32 | 3 | ctd:C419410 | |
| Drug | 8-hydroxyquinoline aluminum | 4.00e-05 | 7 | 32 | 2 | CID000090594 | |
| Drug | 17alpha-estradiol | 5.42e-05 | 1303 | 32 | 9 | CID000000450 | |
| Drug | tripchlorolide | 6.85e-05 | 9 | 32 | 2 | CID000159588 | |
| Drug | 25-hydroxycholesterol | 7.24e-05 | 160 | 32 | 4 | CID000065094 | |
| Drug | probucol | 7.60e-05 | 162 | 32 | 4 | CID000004912 | |
| Drug | AC1NRBPT | 7.60e-05 | 162 | 32 | 4 | CID005288571 | |
| Drug | 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine | 8.55e-05 | 10 | 32 | 2 | ctd:C028145 | |
| Drug | iodide | 8.73e-05 | 534 | 32 | 6 | CID000024841 | |
| Drug | Bouin's solution | 9.01e-05 | 62 | 32 | 3 | CID000124013 | |
| Drug | flurbiprofen | 9.37e-05 | 171 | 32 | 4 | CID000003394 | |
| Drug | napabucasin | 9.91e-05 | 64 | 32 | 3 | ctd:C000621033 | |
| Drug | spinel | 1.04e-04 | 11 | 32 | 2 | CID000159367 | |
| Drug | Withaferin A [5119-48-2]; Up 200; 1uM; MCF7; HT_HG-U133A | 1.05e-04 | 176 | 32 | 4 | 3902_UP | |
| Drug | Epi Lovastatin | 1.06e-04 | 341 | 32 | 5 | CID000003962 | |
| Drug | AC1L9K10 | 1.25e-04 | 12 | 32 | 2 | CID000446726 | |
| Drug | 1,4-dichlorobut-2-ene | 1.25e-04 | 12 | 32 | 2 | CID000015122 | |
| Drug | rhamnose | 1.29e-04 | 356 | 32 | 5 | CID000000840 | |
| Drug | Withaferin A [5119-48-2]; Down 200; 1uM; PC3; HT_HG-U133A | 1.30e-04 | 186 | 32 | 4 | 3819_DN | |
| Drug | 2b1g | 1.35e-04 | 71 | 32 | 3 | CID011963491 | |
| Drug | cast 3 | 1.48e-04 | 13 | 32 | 2 | CID000072360 | |
| Drug | sepiolite | 1.48e-04 | 13 | 32 | 2 | CID000061797 | |
| Drug | 23 p | 1.48e-04 | 13 | 32 | 2 | CID006335913 | |
| Drug | Cyproterone acetate [427-51-0]; Down 200; 9.6uM; PC3; HT_HG-U133A | 1.52e-04 | 194 | 32 | 4 | 4470_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; MCF7; HT_HG-U133A | 1.55e-04 | 195 | 32 | 4 | 2225_UP | |
| Drug | Famprofazone [22881-35-2]; Up 200; 10.6uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 2174_UP | |
| Drug | Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 4169_UP | |
| Drug | Carbimazole [22232-54-8]; Down 200; 21.4uM; HL60; HT_HG-U133A | 1.59e-04 | 196 | 32 | 4 | 2437_DN | |
| Drug | Hydrastine hydrochloride [5936-28-7]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.62e-04 | 197 | 32 | 4 | 2889_UP | |
| Drug | gentamicin | 1.65e-04 | 198 | 32 | 4 | CID000003467 | |
| Drug | Niacin [59-67-6]; Up 200; 32.4uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 6702_UP | |
| Drug | Glimepiride [93479-97-1]; Down 200; 8.2uM; MCF7; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 2809_DN | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 3748_UP | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 1.65e-04 | 198 | 32 | 4 | 7313_UP | |
| Drug | Metronidazole [443-48-1]; Up 200; 23.4uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 4023_UP | |
| Drug | Methiothepin maleate [19728-88-2]; Up 200; 8.4uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 6312_UP | |
| Drug | Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A | 1.68e-04 | 199 | 32 | 4 | 5804_DN | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.71e-04 | 200 | 32 | 4 | 7166_UP | |
| Drug | scopolamine | 1.71e-04 | 200 | 32 | 4 | CID000005184 | |
| Drug | TiCl4 | 1.72e-04 | 14 | 32 | 2 | CID000024193 | |
| Drug | anad | 1.99e-04 | 15 | 32 | 2 | CID005287574 | |
| Drug | epicholesterol | 2.26e-04 | 636 | 32 | 6 | CID000000304 | |
| Drug | 5-aza-2'-deoxycytidine | 2.30e-04 | 638 | 32 | 6 | CID000016886 | |
| Drug | diethyl malate | 2.38e-04 | 86 | 32 | 3 | ctd:C058705 | |
| Drug | gemfibrozil | 2.55e-04 | 222 | 32 | 4 | CID000003463 | |
| Drug | fagomine | 2.57e-04 | 17 | 32 | 2 | CID000072259 | |
| Drug | LMWH | 2.83e-04 | 663 | 32 | 6 | CID000000772 | |
| Drug | L0074 | 2.89e-04 | 18 | 32 | 2 | CID005360046 | |
| Drug | sodium ethoxide | 2.89e-04 | 18 | 32 | 2 | CID002723922 | |
| Drug | siderite | 2.89e-04 | 18 | 32 | 2 | CID000011248 | |
| Drug | 3,3',4,4',5,5'-hexabromobiphenyl | 2.89e-04 | 18 | 32 | 2 | CID000104942 | |
| Drug | TEOS | 3.22e-04 | 19 | 32 | 2 | CID000006517 | |
| Drug | 3-hydroxy-3-methylglutaryl-CoA | 3.27e-04 | 237 | 32 | 4 | CID000000084 | |
| Drug | vitamin E | 3.49e-04 | 441 | 32 | 5 | CID000002116 | |
| Drug | stearylamine | 3.58e-04 | 20 | 32 | 2 | CID000015792 | |
| Drug | tectochrysin | 3.58e-04 | 20 | 32 | 2 | CID005281954 | |
| Drug | silver hydride | 3.58e-04 | 20 | 32 | 2 | CID000139654 | |
| Drug | mangrove | 4.57e-04 | 468 | 32 | 5 | CID000000965 | |
| Drug | magnesium oxide | 4.75e-04 | 23 | 32 | 2 | CID000014792 | |
| Drug | sterol | 4.99e-04 | 265 | 32 | 4 | CID000001107 | |
| Drug | destomycin A | 5.18e-04 | 112 | 32 | 3 | CID000003659 | |
| Drug | manganese tetroxide | 5.18e-04 | 24 | 32 | 2 | CID000014825 | |
| Drug | clioquinol | 5.45e-04 | 114 | 32 | 3 | CID000002788 | |
| Drug | pitavastatin | 5.45e-04 | 114 | 32 | 3 | CID005282451 | |
| Drug | zeolites | 5.63e-04 | 25 | 32 | 2 | CID006432059 | |
| Drug | 1-piperidinocyclohexanecarbonitrile | 5.63e-04 | 25 | 32 | 2 | CID000062529 | |
| Drug | phthalocyanine | 5.63e-04 | 25 | 32 | 2 | CID000168374 | |
| Drug | Si-O | 5.63e-04 | 25 | 32 | 2 | CID000066241 | |
| Drug | hydrotalcite | 6.09e-04 | 26 | 32 | 2 | CID000071749 | |
| Drug | dihydrolipoamide | 6.18e-04 | 119 | 32 | 3 | CID000000663 | |
| Drug | AC1Q5HK6 | 6.23e-04 | 501 | 32 | 5 | CID000003640 | |
| Drug | coelenterazine | 6.57e-04 | 27 | 32 | 2 | CID000002830 | |
| Drug | AC1Q5PO8 | 7.07e-04 | 28 | 32 | 2 | CID000000642 | |
| Drug | ibuprofen | 7.37e-04 | 294 | 32 | 4 | CID000003672 | |
| Drug | lithium chromate | 7.55e-04 | 296 | 32 | 4 | CID000026627 | |
| Drug | tetrahydroaldosterone-3-glucuronide | 7.59e-04 | 29 | 32 | 2 | CID000167918 | |
| Drug | troglitazone | 7.76e-04 | 526 | 32 | 5 | CID000005591 | |
| Drug | enzacamene | 7.82e-04 | 129 | 32 | 3 | ctd:C038939 | |
| Drug | phosphine;hydrate | 8.12e-04 | 30 | 32 | 2 | CID000445832 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 8.68e-04 | 31 | 32 | 2 | ctd:C577942 | |
| Drug | AC1NRAS8 | 9.25e-04 | 32 | 32 | 2 | CID005288068 | |
| Drug | NIPS | 9.25e-04 | 32 | 32 | 2 | CID000196875 | |
| Drug | SureCN2418015 | 9.25e-04 | 32 | 32 | 2 | CID009884138 | |
| Drug | octylmethoxycinnamate | 9.70e-04 | 139 | 32 | 3 | ctd:C118580 | |
| Drug | propan | 9.83e-04 | 33 | 32 | 2 | CID000006334 | |
| Drug | R625 | 9.83e-04 | 33 | 32 | 2 | CID000072375 | |
| Drug | biphenylene | 1.04e-03 | 34 | 32 | 2 | CID000009214 | |
| Drug | ZrO2 | 1.11e-03 | 35 | 32 | 2 | CID000062395 | |
| Drug | Iamin | 1.11e-03 | 35 | 32 | 2 | CID000073587 | |
| Drug | benzamidine | 1.14e-03 | 147 | 32 | 3 | CID000002332 | |
| Drug | ezetimibe | 1.14e-03 | 147 | 32 | 3 | CID000150311 | |
| Disease | Hepatic ductular hypoplasia | 1.14e-06 | 2 | 32 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.14e-06 | 2 | 32 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome | 1.14e-06 | 2 | 32 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.14e-06 | 2 | 32 | 2 | cv:C0085280 | |
| Disease | Alagille Syndrome 2 | 1.14e-06 | 2 | 32 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.14e-06 | 2 | 32 | 2 | C1956125 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.38e-05 | 7 | 32 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.38e-05 | 7 | 32 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | autoimmune thyroiditis (is_implicated_in) | 7.47e-05 | 12 | 32 | 2 | DOID:7188 (is_implicated_in) | |
| Disease | Glioblastoma | 8.66e-05 | 79 | 32 | 3 | C0017636 | |
| Disease | Giant Cell Glioblastoma | 1.04e-04 | 84 | 32 | 3 | C0334588 | |
| Disease | Benign neoplasm of bladder | 1.19e-04 | 15 | 32 | 2 | C0154017 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.19e-04 | 15 | 32 | 2 | C0496930 | |
| Disease | Carcinoma in situ of bladder | 1.19e-04 | 15 | 32 | 2 | C0154091 | |
| Disease | Microangiopathy, Diabetic | 1.35e-04 | 16 | 32 | 2 | C0025945 | |
| Disease | Diabetic Angiopathies | 1.35e-04 | 16 | 32 | 2 | C0011875 | |
| Disease | Carcinoma of bladder | 1.72e-04 | 18 | 32 | 2 | C0699885 | |
| Disease | Glioblastoma Multiforme | 2.37e-04 | 111 | 32 | 3 | C1621958 | |
| Disease | Carcinoma, Pancreatic Ductal | 3.10e-04 | 24 | 32 | 2 | C0887833 | |
| Disease | congenital heart disease (is_implicated_in) | 3.10e-04 | 24 | 32 | 2 | DOID:1682 (is_implicated_in) | |
| Disease | Schizophrenia | 3.29e-04 | 883 | 32 | 6 | C0036341 | |
| Disease | Dwarfism | 3.37e-04 | 25 | 32 | 2 | C0013336 | |
| Disease | Pilocytic Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0334583 | |
| Disease | Cerebral Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0750936 | |
| Disease | Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0004114 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0280785 | |
| Disease | Grade I Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.37e-04 | 25 | 32 | 2 | C0547065 | |
| Disease | Childhood Cerebral Astrocytoma | 3.37e-04 | 25 | 32 | 2 | C0338070 | |
| Disease | corpus collosum mid-posterior volume measurement | 3.37e-04 | 25 | 32 | 2 | EFO_0010300 | |
| Disease | Gemistocytic astrocytoma | 3.64e-04 | 26 | 32 | 2 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 3.64e-04 | 26 | 32 | 2 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 3.64e-04 | 26 | 32 | 2 | C0334582 | |
| Disease | brain cancer (implicated_via_orthology) | 3.64e-04 | 26 | 32 | 2 | DOID:1319 (implicated_via_orthology) | |
| Disease | Anaplastic astrocytoma | 3.93e-04 | 27 | 32 | 2 | C0334579 | |
| Disease | corpus callosum mid-anterior volume measurement | 3.93e-04 | 27 | 32 | 2 | EFO_0010297 | |
| Disease | Child Development Disorders, Specific | 4.54e-04 | 29 | 32 | 2 | C0085997 | |
| Disease | Child Development Deviations | 4.54e-04 | 29 | 32 | 2 | C0085996 | |
| Disease | colorectal cancer (implicated_via_orthology) | 4.86e-04 | 30 | 32 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | Developmental Disabilities | 4.86e-04 | 30 | 32 | 2 | C0008073 | |
| Disease | intestinal cancer (implicated_via_orthology) | 5.54e-04 | 32 | 32 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | pack-years measurement, systolic blood pressure | 6.25e-04 | 34 | 32 | 2 | EFO_0006335, EFO_0006526 | |
| Disease | cervical cancer | 6.25e-04 | 34 | 32 | 2 | C4048328 | |
| Disease | Uterine Cervical Neoplasm | 6.63e-04 | 35 | 32 | 2 | C0007873 | |
| Disease | Lymphoma | 8.66e-04 | 40 | 32 | 2 | C0024299 | |
| Disease | Breast adenocarcinoma | 9.10e-04 | 41 | 32 | 2 | C0858252 | |
| Disease | Diaphragmatic Hernia | 9.10e-04 | 41 | 32 | 2 | C0019284 | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 9.10e-04 | 41 | 32 | 2 | C0496956 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RDDNDPNCTYEGDNN | 441 | O15254 | |
| CEGDDCQPPAYTYNN | 566 | P35858 | |
| QDENNVCFECGAFNP | 16 | Q8N6T3 | |
| CQGKNPQEAESYCAQ | 406 | Q9UGM1 | |
| QAVCENQPLDDICDY | 226 | Q9HCE9 | |
| RPEDQGTYCCQAGQD | 1871 | O75147 | |
| GVNCEYEVDECQNQP | 1181 | Q04721 | |
| YEVDECQNQPCQNGG | 1186 | Q04721 | |
| GQNCEENIDDCPGNN | 251 | P46531 | |
| DRCNYQNHCPNGSDE | 431 | Q9Y561 | |
| EDNVNPCGDDAYCNQ | 3806 | Q9NZR2 | |
| DCYPDENGDSAENCT | 1861 | O43451 | |
| YVDGDQCESNPCLNG | 91 | P00740 | |
| GADENDCQYPTCEQL | 136 | P98164 | |
| NDCQDGSDEHACNYP | 206 | P98164 | |
| NDCGDNSDENPTYCT | 2846 | P98164 | |
| PSGFYQDENCGQQED | 621 | Q8IV76 | |
| EPQDDDYLYCEMCQN | 196 | Q9NQV7 | |
| YQCEEFQLNNDCSSP | 26 | Q8N2G4 | |
| CICNEGYEGPNCEQA | 121 | Q8NFT8 | |
| GAYCETNINDCSQNP | 661 | P78504 | |
| CYPNVCDDDQLLCQN | 451 | Q96CW9 | |
| YPCGICTNEVNDDQD | 341 | Q9Y3Y4 | |
| EPQDDDYLYCEMCQN | 196 | Q9NQW5 | |
| ENGPDCAGCNVEYQS | 681 | Q13591 | |
| SPCDQYECQNGAQCI | 1121 | O75094 | |
| GDRCDNCPYNHNPDQ | 771 | P07996 | |
| NCPYNHNPDQADTDN | 776 | P07996 | |
| PYQCEECGRAFNDNA | 216 | P17023 | |
| PCVGDAAEYQDCNPQ | 891 | Q9P283 | |
| DCPHCEQYNGFQENG | 66 | Q5SNT2 | |
| DDGHQNNQDNCPYIS | 866 | P35442 | |
| CYQCESEDEPQADGS | 691 | Q9HBM0 | |
| EMEYDCENACYNQPG | 1021 | O15016 | |
| QDSGDYAPVQCDVQQ | 121 | P01266 | |
| CPSGYNVEENGRDCQ | 736 | P98155 |